Literature DB >> 18616393

Novel method of murine embryonic stem cell-derived osteoclast development.

Michael L Goodman1, Shi Chen, Feng-Chun Yang, Rebecca J Chan.   

Abstract

Murine embryonic stem (mES) cells are self-renewing pluripotent cells that bear the capacity to differentiate into ectoderm-, endoderm-, and mesoderm-derived tissues. In suspension culture, embryonic stem (ES) cells grow into spherical embryoid bodies (EBs) and are useful for the study of specific gene products in the development and function of various tissue types. Osteoclasts are hematopoietic stem cell-derived cells that participate in bone turnover by secreting resorptive molecules such as hydrochloric acid and acidic proteases, which degrade the bone extracellular matrix. Aberrant osteoclast function leads to dysplastic, erosive, and sclerosing bone diseases. Previous studies have reported the derivation of osteoclasts from mES cells; however, most of these protocols require coculture with stromal cell lines. We describe two simplified, novel methods of stromal cell-independent ES cell-derived osteoclast development.

Entities:  

Mesh:

Year:  2009        PMID: 18616393      PMCID: PMC2975428          DOI: 10.1089/scd.2008.0193

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  15 in total

1.  The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility.

Authors:  M A Chellaiah; K A Hruska
Journal:  Calcif Tissue Int       Date:  2002-12-10       Impact factor: 4.333

2.  Vascular endothelial growth factor receptors in osteoclast differentiation and function.

Authors:  S E Aldridge; T W J Lennard; J R Williams; M A Birch
Journal:  Biochem Biophys Res Commun       Date:  2005-09-30       Impact factor: 3.575

3.  Ascorbic acid promotes osteoclastogenesis from embryonic stem cells.

Authors:  Motokazu Tsuneto; Hidetoshi Yamazaki; Miya Yoshino; Takayuki Yamada; Shin-Ichi Hayashi
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

Review 4.  Lessons from sclerosing bone dysplasias.

Authors:  Wim Van Hul
Journal:  Horm Res       Date:  2007-12-10

5.  p62 ubiquitin binding-associated domain mediated the receptor activator of nuclear factor-kappaB ligand-induced osteoclast formation: a new insight into the pathogenesis of Paget's disease of bone.

Authors:  Kirk H M Yip; Haotian Feng; Nathan J Pavlos; Ming H Zheng; Jiake Xu
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

6.  Map kinase c-JUN N-terminal kinase mediates PMMA induction of osteoclasts.

Authors:  Y Yamanaka; Y Abu-Amer; R Faccio; J C Clohisy
Journal:  J Orthop Res       Date:  2006-07       Impact factor: 3.494

Review 7.  Regulation of osteoclast differentiation.

Authors:  G David Roodman
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

8.  Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Authors:  T Kon; T J Cho; T Aizawa; M Yamazaki; N Nooh; D Graves; L C Gerstenfeld; T A Einhorn
Journal:  J Bone Miner Res       Date:  2001-06       Impact factor: 6.741

Review 9.  Concise review: embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation.

Authors:  Laurence Duplomb; Maylis Dagouassat; Philippe Jourdon; Dominique Heymann
Journal:  Stem Cells       Date:  2006-11-09       Impact factor: 6.277

10.  Discrete types of osteoclast precursors can be generated from embryonic stem cells.

Authors:  Hiromi Okuyama; Motokazu Tsuneto; Toshiyuki Yamane; Hidetoshi Yamazaki; Shin-Ichi Hayashi
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

View more
  2 in total

1.  Development of an in vitro culture method for stepwise differentiation of mouse embryonic stem cells and induced pluripotent stem cells into mature osteoclasts.

Authors:  Keizo Nishikawa; Yoriko Iwamoto; Masaru Ishii
Journal:  J Bone Miner Metab       Date:  2013-12-24       Impact factor: 2.626

2.  The Use of Patient-Specific Induced Pluripotent Stem Cells (iPSCs) to Identify Osteoclast Defects in Rare Genetic Bone Disorders.

Authors:  I-Ping Chen
Journal:  J Clin Med       Date:  2014-12-17       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.